de Weerd L, Weum S, Norderval S
Department of Plastic Surgery and Hand Surgery, University Hospital North Norway, Tromsø, Norway,
Int Urogynecol J. 2015 Jan;26(1):139-44. doi: 10.1007/s00192-014-2497-4. Epub 2014 Sep 9.
The treatment of recurrent rectovaginal fistula (RVF) is a challenge for the surgeon. Within plastic surgery fat harvesting and subsequent transplantation by injection is an established method for soft tissue augmentation. We hypothesized whether soft tissue augmentation by transperineal injection of autologous fat could stimulate fistula healing in women with recalcitrant RVF.
Six patients with a recalcitrant RVF, 4 due to obstetric injury and 2 associated with Crohn's disease, were included in the pilot study. The fat graft from the lower abdomen was injected transperineally around the fistula tract. At the end of the injection procedure the fistula tract was transected transversely.
In 1 patient the fistula healed after a single treatment, while the other 5 required two treatments with a 6-week interval. In the patients with an RVF due to obstetric injury no recurrence occurred during follow-up, mean 41 months (range 4-53). In the 2 patients with Crohn's disease a new fistula developed after 23 and 25 months respectively.
We describe fat injection as a new and promising method for the treatment of a recalcitrant RVF where previous attempts had failed to heal the fistula. This method does not include wide dissection, thereby reducing the risk of injury to important neurovascular structures. The method is minimally invasive and causes minimal donor site morbidity. More advanced techniques can still be used in cases of recurrence.
复发性直肠阴道瘘(RVF)的治疗对外科医生而言是一项挑战。在整形外科领域,脂肪采集及后续注射移植是一种成熟的软组织填充方法。我们推测经会阴注射自体脂肪进行软组织填充是否能促进顽固性RVF女性患者的瘘管愈合。
6例顽固性RVF患者纳入了该初步研究,其中4例因产科损伤所致,2例与克罗恩病相关。将下腹部的脂肪移植物经会阴注射到瘘管周围。注射操作结束时,将瘘管横向切断。
1例患者单次治疗后瘘管愈合,其余5例需间隔6周进行两次治疗。因产科损伤导致RVF的患者在随访期间(平均41个月,范围4 - 53个月)未出现复发。2例克罗恩病患者分别在23个月和25个月后出现了新的瘘管。
我们将脂肪注射描述为一种治疗顽固性RVF的新的且有前景的方法,此前其他治疗方法未能使瘘管愈合。该方法无需广泛解剖,从而降低了损伤重要神经血管结构的风险。此方法微创,供区并发症极少。复发时仍可采用更先进的技术。